GO BLOOD4GOODS: Obtaining high added value products from slaughterhouse waste blood as a sustainable and low-cost management alternative
- Type Grupo operativo
- Status In progress
- Execution 2024 -2027
- Scope Supraautonómico
- Autonomous community Andalucía; Galicia
- Main source of financing PEPAC 2023-2027
- Project website GO Blood4Goods
It is estimated that slaughterhouses in Spain generate 5.1 million tonnes of by-products per year, of which 200 million kg are blood. This by-product is of particular concern from an environmental point of view, which is why the Blood4Goods Project aims to offer a technically viable and sustainable alternative that allows blood from slaughterhouses to be managed by obtaining high added value products.
The sector has the opportunity to take advantage of the opportunities presented by slaughterhouse blood and rely on science and technology to develop low-cost management alternatives that can be adopted by companies so that blood goes from being an undesirable waste to a resource with high added value.
- Production of protein hydrolysates.
- Obtaining high added value biostimulants; obtaining protein-rich food ingredients.
- Validation of biostimulants based on the use of bovine blood hydrolysate in agri-food crops.
- Validation of functional foods based on the use of protein hydrolysates from porcine blood.
- Validation of meat products based on the use of porcine blood protein hydrolysate.
- Comparison of biostimulants formulated with protein hydrolysates of bovine or porcine blood.
- Determination of techno-economic viability, environmental sustainability, and social acceptance.
It is estimated that slaughterhouses in Spain generate 5.1 million tonnes of by-products per year, of which 200 million kg are blood. This by-product is of particular concern from an environmental point of view, given the high volumes generated, their polluting load and their complex composition, which make their management difficult.
Currently, despite its high potential for obtaining high added value products, it is mainly managed as SANDACH waste. Although this entails a significant administrative and legal burden and an associated cost, it is the only economically viable alternative for most companies.
On the one hand, having an on-site protein recovery system, taking into account the alternatives currently available, entails a minimum estimated cost of around €5 million, which is a very high price that the vast majority of companies in the sector cannot afford. An alternative could be centralised treatment systems, however, they also entail a significant investment at an industrial level, in terms of the environmental impact of the activity (on-site activity does not generate new environmental impacts), which limits its development.
They also have a significant environmental impact due to the carbon footprint of transporting waste. Currently, only the large slaughterhouses located in Catalonia and the Mediterranean Arc manage blood in this way, which represents around 30% of the total.
The meat sector needs to focus on taking advantage of the opportunities presented by slaughterhouse blood and rely on science and technology to develop low-cost management alternatives that can be adopted by companies and transform blood from undesirable waste into a valuable resource.
The overall objective is to offer a technically viable and sustainable alternative that allows blood from slaughterhouses to be managed by obtaining high added value products.
Specific objectives:
- To valorise residual bovine/porcine blood as a biostimulant and validate its use in agriculture.
- To valorise residual porcine blood as an ingredient with high protein content and validate its use in functional foods and meat products for human consumption.
- To understand the viability and degree of social acceptance of biostimulants and functional ingredients.
- Valorization of bovine/porcine blood to obtain biostimulants for fertilization.
- Indicators:
- (1) 500 L from bovine blood;
- (2) 1L from porcine blood;
- (3) validation at TRL 6-7 of bovine blood in at least 3 cultures;
- (4) Comparison (laboratory) between bovine and porcine blood biostimulants considering crop productivity and cost/benefit.
- Indicators:
- Obtaining high protein functional ingredients from porcine blood for use in the formulation of food supplements or directly in meat products within the framework of the circular economy.
- Indicators:
- (1) 4 kg of functional ingredients from pig blood for use in food supplements;
- (2) 1 kg of functional ingredients from pig blood;
- (3) TRL 6-7 validation of protein ingredients to be used in the manufacture of at least 1 type of supplement. TRL 5-6 validation of the use of functional ingredients directly in meat products within the meat industry.
- Indicators:
- Provide information on the technical and economic feasibility, environmental sustainability and social acceptability of the solutions developed within the framework of the project.
- Indicator:
- (1) 3 reports
- Indicator:
- Coordinator name: UNION OF COOPERATIVES GALICIAN ASSOCIATION OF AGRICULTURAL COOPERATIVES (AGACA)
- Postal address: RÚA TOMIÑO Nº22 ENTREPLANTA, SANTIAGO DE COMPOSTELA 15703 A CORUÑA (GALICIA)
- Coordinator email: agaca@agaca.coop
- Phone: +34981584911
- Unión de Cooperativas Asociación Galega de Cooperativas Agrarias (AGACA)
- MATADEROS INDUSTRIALES SOLER, S.A. (PROLONGO)
- NOVAFRIGSA SAU
- ASOCIACIÓN NACIONAL DE INDUSTRIAS DE LA CARNE DE ESPAÑA ANICE
- MORENO RUIZ HERMANOS, S.L.
- HEROGRA FERTILIZANTES, S.A.
- Unión de Cooperativas Asociación Galega de Cooperativas Agrarias (AGACA)